The world celebrated last month after Moderna’s long-awaited coronavirus vaccine candidate was found to be 94.5% effective in early clinical results.
But according to New York Magazine, the US pharmaceutical giant finished designing that very same vaccine back on 13 January - just two days after the genetic sequence of the virus had been made public and more than a week before the first confirmed coronavirus case in the US.
The vaccine design reportedly “took all of one weekend” to develop and “was completed before China had even acknowledged that the disease could be transmitted from human to human”.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
And by the time the US reported its first Covid-related death, in February, the Moderna vaccine had “already been manufactured and shipped to the National Institutes of Health for the beginning of its Phase I clinical trial”, the mag continues.
Although the speed of the development effort means that “for the entire span of the pandemic… the US had the tools needed to prevent it”, experts agree that completing intensive trials is vital for the safe rollout of any vaccine.
But as Politico’s London Playbook Emilio Casalicchio notes, “if we had taken a punt and started handing it out (unthinkable, of course), we could be in a different world now”.
Since posting the trial results in November, Moderna has submitted its vaccine candidate for regulatory approval in the US and the EU, “making it the second Western vaccine maker on track to start distribution in December”, the Financial Times reports.
The company says the trial data has also been sent to “regulators where it is already under rolling review, including in the UK”, the paper adds.
-
Sepsis ‘breakthrough’: the world’s first targeted treatment?The Explainer New drug could reverse effects of sepsis, rather than trying to treat infection with antibiotics
-
James Van Der Beek obituary: fresh-faced Dawson’s Creek starIn The Spotlight Van Der Beek fronted one of the most successful teen dramas of the 90s – but his Dawson fame proved a double-edged sword
-
Is Andrew’s arrest the end for the monarchy?Today's Big Question The King has distanced the Royal Family from his disgraced brother but a ‘fit of revolutionary disgust’ could still wipe them out
-
Epstein files topple law CEO, roil UK governmentSpeed Read Peter Mandelson, Britain’s former ambassador to the US, is caught up in the scandal
-
Iran and US prepare to meet after skirmishesSpeed Read The incident comes amid heightened tensions in the Middle East
-
Israel retrieves final hostage’s body from GazaSpeed Read The 24-year-old police officer was killed during the initial Hamas attack
-
China’s Xi targets top general in growing purgeSpeed Read Zhang Youxia is being investigated over ‘grave violations’ of the law
-
Panama and Canada are negotiating over a crucial copper mineIn the Spotlight Panama is set to make a final decision on the mine this summer
-
Why Greenland’s natural resources are nearly impossible to mineThe Explainer The country’s natural landscape makes the task extremely difficult
-
Iran cuts internet as protests escalateSpeed Reada Government buildings across the country have been set on fire
-
US nabs ‘shadow’ tanker claimed by RussiaSpeed Read The ship was one of two vessels seized by the US military
